NeutraKine® IL-17A Monoclonal antibody, PBS Only (Detector)
NeutraKine® IL-17A Monoclonal Antibody for ELISA, Sandwich ELISA, Neutralization, Indirect ELISA
Host / Isotype
Mouse / IgG1
Reactivity
Human
Applications
ELISA, Sandwich ELISA, Neutralization, Indirect ELISA
Conjugate
Unconjugated
CloneNo.
1F3E3
验证数据展示
产品信息
69021-1-PBS targets NeutraKine® IL-17A as part of a matched antibody pair:
MP50004-1: 69021-2-PBS capture and 69021-1-PBS detection (validated in Sandwich ELISA)
Unconjugated mouse monoclonal antibody pair in PBS only (BSA and azide free) storage buffer at a concentration of 1 mg/mL, ready for conjugation.
This conjugation ready format makes antibodies ideal for use in many applications including: ELISAs, multiplex assays requiring matched pairs, mass cytometry, and multiplex imaging applications.Antibody use should be optimized by the end user for each application and assay.
Tested Applications | ELISA, Sandwich ELISA, Neutralization, Indirect ELISA Application Description |
Tested Reactivity | Human |
Immunogen | human Humankine IL-17A protein HZ-1113 种属同源性预测 |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Full Name | interleukin 17A |
Synonyms | CTLA 8, CTLA8, IL 17, IL 17A, IL17, IL-17, IL17A, IL-17A, interleukin 17A, NeutraKine® IL-17A |
Gene Symbol | IL-17A |
Gene ID (NCBI) | 3605 |
ENSEMBL Gene ID | ENSG00000112115 |
Conjugate | Unconjugated |
Form | Lyophilized Powder |
Purification Method | Protein A purification |
Storage Buffer | PBS only |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
背景介绍
This antibody can be used to neutralize the bioactivity of IL-17A.